Angiex, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.angiex.com
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- CancerAdvanced CancerLocally Advanced CarcinomaMetastatic Solid TumorBreast CancerProstate CancerColorectal CancerPancreatic CancerLiver CancerAngiosarcoma
- Interventions
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Angiex, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT06440005
- Locations
- 🇺🇸
NEXT Oncology, San Antonio, Texas, United States
🇺🇸Sarah Cannon Research Center, Nashville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath